Bortezomib in Treating Patients With Metastatic Kidney Cancer

NCT00276614 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer

Interventions

DRUG: bortezomib

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]